Abiraterone Norameda

Medicinal product

(Invented) name

Abiraterone Norameda

Active substance (s)

Abirateronas

Strength

500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02BX03, Abiraterone

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2021-12-13

Date of renewal

2025-08-07

Documents

4866_pakuotes lapelis_2025-08-07.docx

4866_Abir_Norameda_perr2025-08-07.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/4963/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Abirateronas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107724	93829	1093829	lizdinė plokštelė	N56		Receptinis	LT/1/21/4866/001	Netiekiama	-	-	No	-	-
107725	93830	1093830	dalomoji lizdinė plokštelė	N56×1		Receptinis	LT/1/21/4866/002	Netiekiama	-	-	No	-	-
107726	93831	1093831	lizdinė plokštelė	N60		Receptinis	LT/1/21/4866/003	Netiekiama	-	-	No	-	-
107727	93832	1093832	dalomoji lizdinė plokštelė	N60×1		Receptinis	LT/1/21/4866/004	Tiekiama	-	-	No	-	-
107728	93833	1093833	buteliukas	N60		Receptinis	LT/1/21/4866/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-08-07	Perregistruotas
2021-12-13	Registruotas